News: Top stories

Read our latest news stories and see our full press coverage here.

There’s a new edition of A Younger Woman’s Guide to ovarian cancer.

There’s a new edition of A Younger Woman’s Guide to #ovariancancer! Written in collaboration with Target Ovarian Cancer, The Eve Appeal and Ovarian Cancer Action. You can read and download the guide here

We are also happy to put a copy in the post, please contact us on 0800 008 7054 to order your hard copies.


New development in potential blood test to better assist in the diagnosis of ovarian cancer.

ANGLE plc, a world-leading liquid biopsy company, is delighted to announce positive headline results from 400 patient pelvic mass studies, in the US and Europe, demonstrating the potential for a Parsortix based blood test to out-perform current tests in discriminating between benign and malignant pelvic masses. Read the full story here.

Ovacome unveiled results of the biggest patient survey of its kind.

Ovacome unveiled results of the biggest patient survey of its kind, today at the British Gynaecological Cancer Society’s Annual Scientific Meeting in Glasgow. Although almost nine in 10 women diagnosed with ovarian cancer suffer from bloating, in most cases this is not the symptom which prompts them to see their GP.
Read the full story here
Download the press release here

Listen to Nick Coffer on BBC Three Counties Radio talking to Ovacome member Jenny Woods
Listen to Nick Ahad on BBC Radio Leeds talking to Ovacome member Heather Clark



Remembering Helen

We are very saddened to hear that Ovacome supporter Helen Fawkes has died. Helen inspired us all with her List for Living and her determination to live each day to the fullest. We are so grateful to Helen for the contributions she made towards our newsletter over the past few years. Our thoughts are with Helen’s family and friends at this difficult time.…

A trial for drug ONX- 0801 has shown “very promising” results in study with ovarian cancer. 

A small clinical trial saw tumours shrink in 7 of the 15 women taking part. ONX-0801 mimics the ability of folic acid to latch on to cancer cells. Blocking this action causes damage to the DNA and cell death. The researchers hope to carry out bigger clinical trials as soon as possible to confirm the effect of ONX-0801 and that it is safe, as well as which women with ovarian cancer it can effectively help to treat.

MPs and cancer charity Chief Executives send letter to all CCGs regarding earlier diagnosis

All cancer-specific All-Party Parliamentary Groups, Parliamentarians, and 40 cancer charities have joined forces to write to all CCGs in England to highlight the important role they have in improving one-year survival rates, and to offer support in helping to achieve this. You can read the letter here.

Weber county health department Køb cialis bivirkninger af plan b pille